Biogen Idec (BIIB)
|
164.44
+4.14 (+2.58%)
|
|
|
|
BIIB analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BIIB price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
BIIB earnings
Date
Actual
Expected
Prev Yr Qtr
10/25/2012
1.91
1.60
1.61
7/24/2012
1.82
1.56
1.36
5/1/2012
1.40
1.48
1.43
Biogen Idec (BIIB) Upgrades
Date
Analyst
Old Rating
New Rating
01/05/2010
Bank of America
Underperform
Neutral
05/20/2009
Barclays
Underweight
Equalweight
01/27/2009
Goldman Sachs
Neutral
Buy
09/25/2008
Lazard Capital
Hold
Buy
07/22/2008
BMo Capital
Market Perform
Outperform
07/21/2008
Merrill Lynch
Underperform
Buy
Biogen Idec (BIIB) Downgrades
Date
Analyst
Old Rating
New Rating
10/28/2010
Standpoint Research
Buy
HoldThe firm comments
07/20/2009
First Global
Moderate Outperform
Market Perform
07/17/2009
BMo Capital
Outperform
Market Perform
06/29/2009
Deutsche Bank
Buy
Hold
10/16/2007
Piper Jaffray & Co.
Market Perform
Underperform
10/02/2007
Credit Suisse
Neutral
Underperform
Biogen Idec (BIIB) New Coverage
Date
Analyst
Rating
11/09/2012
Guggenheim
Buy
11/16/2010
UBS
Neutral
08/16/2010
Deutsche Bank
Hold $ 57 Target
01/19/2010
Standpoint Research
Buy
08/26/2009
William Blair
Market Perform
09/10/2008
Stanford
Buy
